Will Singleterry BS, PhD

Will Singleterry, PhD, is a T Cell Immunologist who received his Doctoral Degree from the University of Mississippi Medical Center and completed his Post-Doctoral Training at St Jude Children’s Research Hospital. He now serves as the Director of Business Development for IsoPlexis, a venture capital-funded life sciences company dedicated to accelerating the fight against cancer through its single-cell proteomics platform. Dr Singleterry manages the collaborations between IsoPlexis and their Bio-Pharmaceutical partners, using IsoPlexis’ single-cell technologies to reveal the highly functional cell subsets driving clinical response in Immunotherapy.